Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer
Conclusion: Beclin-1 regulated by miR-30a-5p plays a notable role in the drug-resistance of SCLC. Inhibition of Beclin-1 by induction of miR-30a-5p may improve the therapeutic outcome via resensitizing the drug-resistant cells to chemotherapy in SCLC.Cell Physiol Biochem 2017;43:1126 –1139
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Chemotherapy | Cytology | Environmental Health | Lung Cancer | Physiology | Small Cell Lung Cancer | Study